Diseases, Conditions, Syndromes News

Diseases, Conditions, Syndromes News

Measles has killed more than 6,000 people in the Democratic Republic of Congo since January, the world's worst outbreak and nearly triple the toll in the country's Ebola epidemic, the World Health Organization said Tuesday. DR Congo declared its latest measles epidemic in June, and last September the country launched an emergency vaccination campaign to counter the outbreak. In 2019, more than 18 million children under the age of 5 were vaccinated across the DR Congo, the WHO said in a statement. Around 310,000 suspected cases were reported during the year, it said. WHO said an additional $40 million in emergency funds was needed from donors for a six-month immunisation plan for children to help curb the epidemic. Efforts to halt the spread of both Ebola and measles are hampered by a lack of access, weak health care and unrest across the country, especially in the east. Measles is a highly- contagious disease caused by a virus that attacks mainly children. The most serious complications include blindness, brain swelling, diarrhoea, and severe respiratory infections. The rapid spread of measles in DRC has garnered far less attention than the Ebola epidemic that has also been raging in the east of the country since August 2018. That outbreak has killed more than 2,230 people. Explore further Measles kill more people in DR Congo than Ebola: NGO © 2020 AFP Citation : DR Congo measles outbreak kills 6,000 in a year: WHO (2020, January 7) retrieved 7 January 2020 from https://medicalxpress.com/news/2020-01-dr-congo-measles-outbreak-year.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More